Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	223.96	317.5	474.88	651.55	1,029	712.36
Short-Term Investments	761.9	591.22	658.47	696.8	366.3	871.2
Trading Asset Securities	-	-	18.66	17.77	19.65	20.71
Cash & Short-Term Investments	985.86	908.72	1,152	1,366	1,415	1,604
Cash Growth	-19.17%	-21.12%	-15.67%	-3.43%	-11.82%	-1.48%
Accounts Receivable	221.36	175.16	138.92	130.52	149.05	102.34
Other Receivables	10.12	2.61	2.8	1.84	2.06	306.62
Receivables	231.48	177.77	141.71	132.36	151.11	408.97
Inventory	154.6	161.79	188.76	115.2	115.18	103.02
Prepaid Expenses	17.32	12.21	16.43	3.84	7.84	8.44
Other Current Assets	5.89	8.26	125.78	2.04	2.13	0.3
Total Current Assets	1,395	1,269	1,625	1,620	1,691	2,125
Property, Plant & Equipment	28.35	29.51	7.65	14.54	22.51	28.82
Long-Term Investments	478.5	418.6	119.7	134.74	93.33	77.48
Other Intangible Assets	0.55	0.6	0.79	0.05	0.25	2.91
Long-Term Accounts Receivable	-	17.1	-	1.99	6.68	11.25
Long-Term Deferred Tax Assets	8.06	10.41	7.77	6.71	10.07	8.76
Other Long-Term Assets	20.73	4.81	4.83	5.63	7.33	10.74
Total Assets	1,931	1,750	1,765	1,783	1,831	2,265
Accounts Payable	59.52	25.9	62.69	46.71	89.95	28.52
Accrued Expenses	-	71.59	90.73	80.1	95.23	51
Current Portion of Leases	9.89	9.81	5.05	10.08	9.83	9.39
Current Income Taxes Payable	90.32	56.41	80.35	40.51	40.15	121.39
Current Unearned Revenue	13.77	11.52	8.26	8.05	13.59	12.44
Other Current Liabilities	197.66	77.98	41.8	33.75	30.42	17.56
Total Current Liabilities	371.16	253.2	288.88	219.18	279.16	240.3
Long-Term Leases	34.46	36.96	-	5.6	15.68	24.59
Long-Term Deferred Tax Liabilities	4.64	3.3	0.98	28.18	-	-
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.26	1.49
Total Liabilities	411.52	294.71	291.12	254.22	296.1	266.37
Common Stock	450.48	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	241.8	241.8	331.89	421.99	512.08	692.27
Retained Earnings	827.53	762.78	691.96	548.78	479.09	778.38
Comprehensive Income & Other	-	-	-	107.77	93.31	77.45
Shareholders' Equity	1,520	1,455	1,474	1,529	1,535	1,999
Total Liabilities & Equity	1,931	1,750	1,765	1,783	1,831	2,265
Total Debt	44.35	46.77	5.05	15.68	25.5	33.98
Net Cash (Debt)	941.51	861.95	1,147	1,350	1,389	1,570
Net Cash Growth	-22.65%	-24.85%	-15.07%	-2.78%	-11.54%	-0.94%
Net Cash Per Share	20.83	19.08	25.44	29.95	30.80	34.76
Filing Date Shares Outstanding	45.01	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	45.01	45.05	45.05	45.05	45.05	45.05
Working Capital	1,024	1,016	1,336	1,400	1,412	1,885
Book Value Per Share	33.76	32.30	32.73	33.94	34.07	44.37
Tangible Book Value	1,519	1,454	1,474	1,529	1,535	1,996
Tangible Book Value Per Share	33.75	32.29	32.71	33.94	34.07	44.30
Machinery	-	-	-	-	-	1
Leasehold Improvements	-	-	-	-	-	20.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.